Compare CRC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRC | RLAY |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.1B |
| IPO Year | N/A | 2020 |
| Metric | CRC | RLAY |
|---|---|---|
| Price | $53.96 | $20.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $72.57 | $19.50 |
| AVG Volume (30 Days) | 740.0K | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $12.37 | N/A |
| Revenue Next Year | N/A | $324.03 |
| P/E Ratio | $13.50 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $43.25 | $3.24 |
| 52 Week High | $71.98 | $20.79 |
| Indicator | CRC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 61.66 |
| Support Level | $50.27 | $18.02 |
| Resistance Level | $54.86 | $20.59 |
| Average True Range (ATR) | 1.75 | 1.00 |
| MACD | 0.34 | -0.01 |
| Stochastic Oscillator | 72.84 | 79.67 |
California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.